secwatch.observer — SEC 8-K summary
======================================

Issuer:     PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT)
CIK:        0000315545
Form:       8-K
Filed at:   2026-06-22T13:00:29+00:00
Accession:  0001493152-26-029512
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Provectus shareholders elect directors, approve reverse stock split authorization
--------------------------------------------------------------------------------

- Directors elected: Webster Bailey, John Lacey III, Ed Pershing, Dominic Rodrigues.
- Advisory vote on executive compensation passed with 190M for vs 17M against.
- Ratification of CBIZ CPAs as auditor for 2026 passed with 330M for.
- Reverse stock split authorized (ratio 1:10 to 1:50) with 315M for, 24M against.
- Authorized share decrease (by same ratio) approved with 312M for, 22M against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/315545/000149315226029512/0001493152-26-029512-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/315545/000149315226029512/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-029512

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer